BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28644271)

  • 1. Norepinephrine Shortage Led to Increased Deaths from Septic Shock.
    Stockwell S
    Am J Nurs; 2017 Jul; 117(7):15. PubMed ID: 28644271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Practice Changes in the Care of Patients with Septic Shock during the U.S. Norepinephrine Shortage.
    Wunsch H; Hua M; Walkey AJ; Rubenfeld G; Vail E; Gershengorn HB
    Ann Am Thorac Soc; 2018 Apr; 15(4):509-511. PubMed ID: 29537858
    [No Abstract]   [Full Text] [Related]  

  • 3. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.
    Vail E; Gershengorn HB; Hua M; Walkey AJ; Rubenfeld G; Wunsch H
    JAMA; 2017 Apr; 317(14):1433-1442. PubMed ID: 28322415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the addition of vasopressin to norepinephrine beneficial for the treatment of septic shock?
    Sandifer JP; Jones AE
    Ann Emerg Med; 2013 Nov; 62(5):534-535. PubMed ID: 23683544
    [No Abstract]   [Full Text] [Related]  

  • 6. Vasopressin in septic shock: clinical equipoise mandates a time for restraint.
    Russell JA
    Crit Care Med; 2003 Nov; 31(11):2707-9. PubMed ID: 14605551
    [No Abstract]   [Full Text] [Related]  

  • 7. Terlipressin for norepinephrine-resistant septic shock.
    O'Brien A; Clapp L; Singer M
    Lancet; 2002 Apr; 359(9313):1209-10. PubMed ID: 11955542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
    Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norepinephrine vs. dopamine: new recommendations for initial vasopressor selection in septic shock.
    Bartel B
    S D Med; 2014 May; 67(5):200-1. PubMed ID: 24851468
    [No Abstract]   [Full Text] [Related]  

  • 10. Weapons of pressure resuscitation for septic shock.
    Martin C
    Intensive Care Med; 2003 Oct; 29(10):1621-2. PubMed ID: 12942169
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine therapy in septic shock: detrimental effect on survival?
    Boulain T; Runge I; Bercault N; Benzekri-Lefevre D; Wolf M; Fleury C
    J Crit Care; 2009 Dec; 24(4):575-82. PubMed ID: 19327324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US drug shortages might have led to more patient deaths.
    Furlow B
    Lancet Respir Med; 2017 Jun; 5(6):469. PubMed ID: 28438502
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of hypotension in septic shock.
    Pastor CM; Morel DR
    Lancet; 1996 Mar; 347(9001):622; author reply 622-3. PubMed ID: 8596355
    [No Abstract]   [Full Text] [Related]  

  • 14. Norepinephrine administration in septic shock: how much is enough?
    De Backer D; Vincent JL
    Crit Care Med; 2002 Jun; 30(6):1398-9. PubMed ID: 12072710
    [No Abstract]   [Full Text] [Related]  

  • 15. Terlipressin in the treatment of late phase catecholamine-resistant septic shock.
    Svoboda P; Scheer P; Kantorová I; Doubek J; Dudra J; Radvan M; Radvanova J
    Hepatogastroenterology; 2012 Jun; 59(116):1043-7. PubMed ID: 22580654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
    Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
    J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship Between Norepinephrine Equivalent Dose of Vasopressors Within 24 Hours From the Onset of Septic Shock and In-Hospital Mortality Rate.
    Sato R; Duggal A; Sacha GL; Rudoni MA; Yataco AC; Khanna AK; Dugar S
    Chest; 2023 Jan; 163(1):148-151. PubMed ID: 35921884
    [No Abstract]   [Full Text] [Related]  

  • 18. Refractory septic shock: efficacy and safety of very high doses of norepinephrine.
    Katsaragakis S; Kapralou A; Theodorou D; Markogiannakis H; Larentzakis A; Stamou KM; Drimousis P; Bramis I
    Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):307-13. PubMed ID: 16845448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is vasopressin increasing or decreasing mortality in patients with septic shock?
    Rehberg S; Ertmer C; Van Aken H; Westphal M
    Surg Infect (Larchmt); 2008 Apr; 9(2):215 author reply 216. PubMed ID: 18426355
    [No Abstract]   [Full Text] [Related]  

  • 20. beta2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock.
    Nakada TA; Russell JA; Boyd JH; Aguirre-Hernandez R; Thain KR; Thair SA; Nakada E; McConechy M; Walley KR
    Am J Respir Crit Care Med; 2010 Jan; 181(2):143-9. PubMed ID: 19850944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.